Form D · Other Technology

Reverse Medical Corp

Irvine, CA · CIK 0001415499

Offering snapshot reported Mar 24, 2010 · SEC filing

Reported sold: $13.8M
Investors reported: 22
Minimum accepted: $0
First sale: Feb 19, 2010

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$12,803,677 → $13,808,677
Reported investors21 → 22

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 24, 2010	Amendment	$13,808,677	$1,005,000vs Mar 2, 2010	22	SEC filing
Mar 2, 2010	Initial	$12,803,677	No comparison	21	SEC filing
Jul 1, 2009	Initial	$1,500,000	No comparison	12	SEC filing
Oct 15, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-109871

Source: Form D, filed Mar 24, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Aris Constantinides	Director
John Geis	Director
Michael R. Henson	Director, Executive
Paul Meiyal	Director
Jeffrey J. Valko	Director, Executive
John Yianni	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

13900 Alton Parkway Suite 125
Irvine, CA, 92618